ClinicalTrials.gg
RecruitingNCT07872202Updated Oct 13, 2026

To Assess Self-sufficiency in Parkinson's Patients and How Rehabilitation Affects Symptoms Linked to Independence

An interventional study of EXERCISE TRAINING WITH OR WITHOUT MEDICATION in Parkinson's Disease (PD), sponsored by Palacky University. Recruiting at 1 site in Czechia. Open to participants aged 50 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by Palacky University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 7 months after the study started (first participant enrolled Nov 2024, registered Jun 2026).
  • Started Nov 2024; still recruiting 1 year 11 months later.
Updated Oct 13, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
50 Years to 80 Years
Sex
All
01

Study summary

This interventional study aims to assess self-sufficiency in patients with Parkinson's disease in the spa setting using the new Czech Functional Efficiency of Self-sufficiency Test (FEST) and to validate the test in this population. It also aims to evaluate changes in cognition, stability, fear of falling, and gait after specialized spa care and to analyze correlations between self-sufficiency and these outcomes.

Read the detailed description

The research includes the validation of a Czech self-sufficiency test designed primarily for patients after a stroke. The aim is to validate this tool in patients with Parkinson's disease (PD). The research will also include the possible modification of certain categories that are characteristic of PD patients, as well as the scoring of the test. The study will include patients undergoing comprehensive spa treatment at a Czech spa facility. The inclusion criteria are: 1/idiopathic PD, 2/disease severity 1-3 according to the Hoehn and Yahr scale, 3/age 50-80 years, 4/ability to walk independently, 5/minimum score ≤76 in Adenbrooke's Cognitive Examination. Exclusion criteria: 1/moderate to severe dementia, 2/other comorbidities affecting the gait (e.g. post-stroke condition, vertigo,...), 3/psychiatric disorders, 4/severe sensory impairments that would limit the implementation of the rehabilitation plan. The research will also evaluate changes in selected parameters, namely: cognition, stability, gait, and fear of falling. The research will also examine whether there is a correlation between self-sufficiency and these factors. Patients will be tested upon admission to care, then undergo a 3-week rehabilitation program, followed by a follow-up measurement.

Standardized tests were selected for research purposes:

Self-sufficiency: Barthel Index, FEST Fear of falling: Short Falls Efficacy Scale - International Stability: Mini-Balance Evaluation Systems Test, measurement on a stabilometric platform Cognition: Adenbrooke's Cognitive Examination (ACE-III) Gait: 6-minute walk test Descriptive statistics and correlation will be used for data processing.

02

Conditions studied

  • Parkinson's Disease (PD)

Browse trials for

Keywords

  • Parkinson's disease
  • self-sufficiency
  • spa care
  • rehabilitation
03

In context

Parkinson Disease

4,583 studies on the registry are indexed under Parkinson Disease; 1,097 are open to participants now.

This study's planned enrollment of 50 is above the median of 40 across 3,365 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

Palacky University is the lead sponsor of 32 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Idiopathic PD,
  • severity level 1 - 3 according to the Hoehn and Yahr scale,
  • age 50-80 years,
  • the ability to walk independently,
  • a minimum score of ≤76 on the Adenbrooke's Cognitive Test.

Exclusion criteria

Exclusion Criteria:

  • moderate to severe dementia,
  • other comorbidities affecting the gait (e.g. post-stroke condition, vertigo,...), psychiatric disorders,
  • severe sensory impairments that would limit the implementation of the rehabilitation plan.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Parkinson's disease patients

    Patients with Parkinson's disease undergo comprehensive spa treatment, which includes: individual therapeutic physical education, group exercises - exercises on balance balls, exercises in the pool, balance training on Nintendo Wii, Nordic walking, Qi Gong. In addition to active therapy, the treatment also utilizes the effects of natural resources on the body - iodine-bromine water in the form of compresses and baths, massages - aromatherapy, classic massages.

    Other: EXERCISE TRAINING WITH OR WITHOUT MEDICATION

Interventions

  • OtherEXERCISE TRAINING WITH OR WITHOUT MEDICATION

    Patients undergo therapies led by clinical experts in the field of physical therapy. Individual therapies include soft tissue therapies, exercises aimed at increasing/maintaining range of motion, increasing muscle strength, balance, cognition, and self-sufficiency. The comprehensive rehabilitation stay will also include the use of natural healing resources - iodine-bromine brine, combined with active therapy.

    Also known as: Active exercising, rehabilitation care

06

What researchers measure

Primary outcomes

  1. Change in Self-Sufficiency Test Score

    Change in the total score of the Functional Efficiency of Self-Sufficiency Test from baseline to completion of the rehabilitation program. The total score ranges from 0 to 100 points, with higher scores indicating greater functional independence. Unit of measure: points Measurement tool: Functional Efficiency of Self-Sufficiency Test

    Time frame: 3 weeks

  2. Change in Addenbrooke's Cognitive Examination III (ACE-III) Score

    Change in the total Addenbrooke's Cognitive Examination III (ACE-III) score from baseline to completion of the rehabilitation program. The ACE-III total score ranges from 0 to 100 points, with higher scores indicating better cognitive performance. Unit of measure: points Measurement tool: Addenbrooke's Cognitive Examination III (ACE-III)

    Time frame: 3 weeks

  3. Change in Short Falls Efficacy Scale-International (Short FES-I) Score

    Change in the total Short Falls Efficacy Scale-International (Short FES-I) score from baseline to completion of the rehabilitation program. The total score ranges from 7 to 28 points, with higher scores indicating greater concern about falling. Unit of measure: points Measurement tool: Short Falls Efficacy Scale-International (Short FES-I)

    Time frame: 3 weeks

  4. Change in Mini-BESTest Score

    Change in the total Mini-Balance Evaluation Systems Test (Mini-BESTest) score from baseline to completion of the rehabilitation program. The total score ranges from 0 to 28 points, with higher scores indicating better dynamic balance. Unit of measure: points Measurement tool: Mini-Balance Evaluation Systems Test (Mini-BESTest)

    Time frame: 3 weeks

  5. Change in Weight-Bearing Asymmetry Measured Using a Force Platform

    Change in weight-bearing asymmetry during 30-second quiet standing from baseline to completion of the rehabilitation program, measured using a force platform. Weight-bearing asymmetry is expressed as the absolute difference between the percentage load on the left and right sides. Lower values indicate more symmetrical weight distribution. Unit of measure: percentage points Measurement tool: Force platform

    Time frame: 3 weeks

  6. Change in Six-Minute Walk Test Distance

    Change in the distance walked during the Six-Minute Walk Test (6MWT) from baseline to completion of the rehabilitation program. A greater walking distance indicates better functional exercise capacity. Unit of measure: meters (m) Measurement tool: Six-Minute Walk Test (6MWT)

    Time frame: 3 weeks

07

Study locations

1 of 1 sites recruiting
  • Faculty of Health Sciences, Palacky University, Olomouc
    Olomouc, 775 15, Czechia
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2024 (actual). Primary completion is estimated for Mar 2027, 28 months after the start.

Of 1,296 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 45. This study's planned 28 months is above that.

Counting every sponsor, half of 1,369 studies reached it within 24 months; a quarter within 11 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 28, 2026
First posted
Oct 13, 2026
StartActual
Nov 1, 2024
Primary completionEst.
Mar 2027
CompletionEst.
Mar 1, 2027
Last update
Oct 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07872202
Lead sponsor
Palacky University
Responsible party
Zuzana Turiakova (PhD Student, Palacky University) — Principal investigator
First posted
Oct 13, 2026
Start date
Nov 1, 2024
Primary completion
Mar 2027 (estimated)
Completion
Mar 1, 2027 (estimated)
Last update
Oct 13, 2026

Study contacts

Zuzana Turiaková, Mgr. (MSc.)
Contact
zuzana.turiakova01@upol.cz
+420724331263
Helena Kisvetrová, Ass.Prof.
principal investigator · Doctoral Study Office, Faculty of Health Sciences, Palacky University, Olomouc

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion